International Stem Cell Co. (OTCMKTS:ISCO) Short Interest Down 25.0% in April

International Stem Cell Co. (OTCMKTS:ISCOGet Rating) was the recipient of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 300 shares, a drop of 25.0% from the March 31st total of 400 shares. Based on an average trading volume of 2,200 shares, the short-interest ratio is currently 0.1 days.

Shares of International Stem Cell stock opened at $0.44 on Monday. International Stem Cell has a twelve month low of $0.30 and a twelve month high of $0.80. The firm’s 50-day moving average price is $0.43 and its 200 day moving average price is $0.46.

About International Stem Cell (Get Rating)

International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes.

See Also

Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.